ReviewInternational journal of hematology2020

Emicizumab, a humanized bispecific antibody to coagulation factors IXa and X with a factor VIIIa-cofactor activity.

Takehisa Kitazawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.